The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2018.1389885
Abstract: ABSTRACT Introduction: The recent failure of several clinical trials on anti-β-amyloid (Aβ) drugs in Alzheimer’s disease (AD) suggested earlier intervention in the disease course. Secondary prevention trials have been started in autosomal-dominant AD (ADAD) individuals… read more here.
Keywords: alzheimer disease; solanezumab gantenerumab; disease; prevention trials ... See more keywords